Personal information

No personal information available

Activities

Collapse all

Employment (2)

Yale University School of Medicine: New Haven, CT, US

2006 to present | Professor (Epidemiology & Public Health)
Employment
Source: Self-asserted source
Richard Bucala

Yale University School of Medicine: New Haven, CT, US

2002 to present | Professor (Medicine &Pathology)
Employment
Source: Self-asserted source
Richard Bucala

Education and qualifications (2)

Cornell University: Ithaca, NY, US

1986 to present | MD
Education
Source: Self-asserted source
Richard Bucala

Rockefeller University: New York, NY, US

1985 to present | PhD (Biochemistry)
Education
Source: Self-asserted source
Richard Bucala

Works (18)

“Rounding Third Base and Heading Home”: Arthritis & Rheumatology in 2024

Arthritis & Rheumatology
2024-06 | Journal article
DOI: 10.1002/art.42828
Contributors: Daniel H. Solomon; Mariana J. Kaplan; Peter A. Nigrovic; Richard Bucala
Source: check_circle
Crossref

A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation

Metabolism
2024-04 | Journal article
DOI: 10.1016/j.metabol.2024.155792
Contributors: Hao Wang; Lily Slotabec; Steven Didik; Zehui Li; Lin Leng; Bi Zhao; Richard Bucala; Ji Li
Source: check_circle
Crossref

The Emerging Spectrum of Somatic Mutation in Rheumatic Disease: Clonal Hematopoiesis Connects Aging With Giant Cell Arteritis

Arthritis & Rheumatology
2024-03 | Journal article
DOI: 10.1002/art.42745
Contributors: Richard Bucala; Betty P. Tsao
Source: check_circle
Crossref

Immunology for the Rheumatologist: Arthritis & Rheumatology Introduces a New Problem‐Based Immunology Review Series With Great Educational Potential

Arthritis & Rheumatology
2024-01 | Journal article
DOI: 10.1002/art.42688
Contributors: Richard Bucala; Daniel H. Solomon
Source: check_circle
Crossref

Macrophage migration inhibitory factor regulates specific innate immune sensor responses in gingival epithelial cells

Journal of Periodontology
2022-12 | Journal article
DOI: 10.1002/JPER.21-0598
Contributors: Nutthapong Kantrong; Ana M. Chang; Shatha Bamashmous; Adeline M. Hajjar; Richard J. Bucala; Richard P. Darveau
Source: check_circle
Crossref

Arthritis & Rheumatology: “Mid‐Term” Report

Arthritis & Rheumatology
2022-07 | Journal article
DOI: 10.1002/art.42131
Contributors: Daniel H. Solomon; Richard Bucala; Mariana J. Kaplan; Peter A. Nigrovic
Source: check_circle
Crossref

Interferons and cytokines in SLE pathogenesis and therapy

2021 | Book chapter
DOI: 10.1016/B978-0-12-820583-9.00015-4
Contributors: Fotios Koumpouras; Richard Bucala
Source: check_circle
Crossref

ICBP90 Regulates MIF Expression, Glucocorticoid Sensitivity, and Apoptosis at the MIF Immune Susceptibility Locus

Arthritis & Rheumatology
2021-10 | Journal article
DOI: 10.1002/art.41753
Contributors: Jie Yao; Lin Leng; Weiling Fu; Jia Li; Christian Bronner; Richard Bucala
Source: check_circle
Crossref

Global Rheumatology Research: Frontiers, Challenges, and Opportunities

Arthritis & Rheumatology
2021-09-17 | Journal article
DOI: 10.1002/art.41980
Contributors: Joshua B. Bilsborrow; Ingris Peláez‐Ballestas; Bernardo Pons‐Estel; Christiaan Scott; Xinping Tian; Graciela S. Alarcon; Richard Bucala; Laura B. Lewandowski; Evelyn Hsieh
Source: check_circle
Crossref

Suppression ofPlasmodiumMIF-CD74 Signaling Protects Against Severe Malaria

2021-02-14 | Preprint
DOI: 10.1101/2021.02.14.430970
Contributors: Alvaro Baeza Garcia; Edwin Siu; Xin Du; Lin Leng; Blandine Franke-Fayard; Chris J Janse; Shanshan W Howland; Laurent Rénia; Elias Lolis; Richard Bucala
Source: check_circle
Crossref

Extracellular MIF, but not its homologue D-DT, promotes fibroblast motility independently of its receptor complex CD74/CD44

Journal of Cell Science
2021-02-01 | Journal article
DOI: 10.1242/jcs.217356
Contributors: Paweł Szczęśniak; Tamara Henke; Suada Fröhlich; Uwe Plessmann; Henning Urlaub; Lin Leng; Richard Bucala; Robert Grosse; Andreas Meinhardt; Jörg Klug
Source: check_circle
Crossref

The “Infodemic” of COVID‐19

Arthritis & Rheumatology
2020-11 | Journal article
DOI: 10.1002/art.41468
Contributors: Daniel H. Solomon; Richard Bucala; Mariana J. Kaplan; Peter A. Nigrovic
Source: check_circle
Crossref

Arthritis & Rheumatology: Evolving to Meet the Challenges of Rheumatology

Arthritis & Rheumatology
2020-08 | Journal article
DOI: 10.1002/art.41303
Contributors: Daniel H. Solomon; Richard J. Bucala; Mariana J. Kaplan; Peter A. Nigrovic
Source: check_circle
Crossref

Rheumatology Forecast: Why Prevention Matters

Arthritis & Rheumatology
2020-06 | Journal article
DOI: 10.1002/art.41216
Contributors: Richard J. Bucala
Source: check_circle
Crossref

Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico

Molecular Genetics & Genomic Medicine
2020-01 | Journal article
DOI: 10.1002/mgg3.1037
Contributors: Guillermo Santoscoy‐Ascencio; Christian Johana Baños‐Hernández; José Eduardo Navarro‐Zarza; Jorge Hernández‐Bello; Richard Bucala; Andres López‐Quintero; Emmanuel Valdés‐Alvarado; Isela Parra‐Rojas; Berenice Illades‐Aguiar; José Francisco Muñoz‐Valle
Source: check_circle
Crossref

The immunobiology of MIF: function, genetics and prospects for precision medicine

Nature Reviews Rheumatology
2019-07 | Journal article
DOI: 10.1038/s41584-019-0238-2
Contributors: Insoo Kang; Richard Bucala
Source: check_circle
Crossref

A Fresh New Look, and a Fresh New Journal

Arthritis & Rheumatology
2019-01 | Journal article
DOI: 10.1002/art.40717
Contributors: Richard J. Bucala; Marian T. Hannan
Source: check_circle
Crossref

A Fresh New Look, and a Fresh New Journal

Arthritis Care & Research
2019-01 | Journal article
DOI: 10.1002/acr.23751
Contributors: Marian T. Hannan; Richard J. Bucala
Source: check_circle
Crossref

Peer review (2 reviews for 2 publications/grants)

Review activity for Cardiovascular drugs and therapy. (1)
Review activity for PLoS neglected tropical diseases (1)
How many people are using ORCID?